Annamaria Vincenzi, Marco Picardi, Claudia Giordano, Novella Pugliese, Sara Pellegrino, Fabrizio Pane. Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70951. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70951?af=R
Annamaria Vincenzi, Marco Picardi, Claudia Giordano, Novella Pugliese, Sara Pellegrino, & Fabrizio Pane (2026). Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.70951
Annamaria Vincenzi, et al. “Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma.” British Journal of Haematology, 2026. doi:10.1111/bjh.70951.
@article{Vincenzi2026,
title = {Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma},
author = {Vincenzi, Annamaria and Picardi, Marco and Giordano, Claudia and Pugliese, Novella and Pellegrino, Sara and Pane, Fabrizio},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70951},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70951?af=R}
}